Position in GOVX
as of Mar 31, 2026
· filed Apr 10, 2026
Position Value
$1
+$0 QoQ
Shares Held
1
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GOVX Over Time
Shares Held
Position Value (USD)
Derivatives in GOVX
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$1
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quaker Wealth Management, LLC holds $503,825 across 19 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZVRA |
Zevra Therapeutics, Inc.
|
19,367 | $277,722 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
2,880 | $112,348 | |
| 3 | IVA |
Inventiva S.A.
|
24,960 | $94,348 | |
| 4 | SRPT |
Sarepta Therapeutics, Inc.
|
400 | $7,188 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7 | $3,477 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
8 | $1,498 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2 | $1,247 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
15 | $1,189 |
All Filings in GOVX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1 | 1 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $1 | 1 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1 | 1 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1 | 1 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1 | 1 | Put | Sole | 2025-05-29 | |
| No filing history on record for this holder in this stock. | ||||||